Saltar al contenido
Merck

Optimized protocol to detect protein UFMylation in cells and in vitro via immunoblotting.

STAR protocols (2022-01-18)
Junzhi Zhou, Qian Liang, Maogong Dong, Xiaohe Ma, Yaqi Jin, Di Guan, Jiang Liu, Miao Wang, Yu-Sheng Cong
RESUMEN

Ubiquitin-fold modifier 1 (UFM1) system is a recently identified ubiquitin-like modification with essential biological functions. Similar to ubiquitination, the covalent conjugation of UFM1 (UFMylation) to target proteins involves a three-step enzymatic cascade catalyzed sequentially by UFM1-activating enzyme 5 (UBA5, E1), UFM1-conjugating enzyme 1 (UFC1, E2), and UFM1-specific ligase 1 (UFL1, E3). Here, we provide an optimized protocol adapted to previously reported methods for detecting the UFMylation of target protein in human cells and in vitro assays, respectively, with high reliability and reproducibility. For complete details on the use and execution of this protocol, please refer to Liu et al. (2020).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Millipore
Gel ANTI-FLAG® M2 Affinity, purified immunoglobulin, buffered aqueous glycerol solution
Millipore
ANTI-FLAG® antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
IgG anti-ratón (molécula completa)-Peroxidasa antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
IgG anti-conejo (molécula completa)-Peroxidasa antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution